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Background: Next Generation Sequencing has proven to be an exceptionally powerful tool in the field of genomics
and transcriptomics. With recent development it is nowadays possible to analyze ultra-low input sample material down
to single cells. Nevertheless, investigating such sample material often limits the analysis to either the genome or
transcriptome. We describe here a combined analysis of both types of nucleic acids from the same sample material.
Methods: The method described enables the combined preparation of amplified cDNA as well as amplified whole-
genome DNA from an ultra-low input sample material derived from a sub-colony of in-vitro cultivated human
embryonic stem cells. cDNA is prepared by the application of oligo-dT coupled magnetic beads for mRNA capture, first
strand synthesis and 3’-tailing followed by PCR. Whole-genome amplified DNA is prepared by Phi29 mediated
amplification. Illumina sequencing is applied to short fragment libraries prepared from the amplified samples.
Results: We developed a protocol which enables the combined analysis of the genome as well as the transcriptome
by Next Generation Sequencing from ultra-low input samples. The protocol was evaluated by sequencing sub-colony
structures from human embryonic stem cells containing 150 to 200 cells. The method can be adapted to any available
sequencing system.
Conclusions: To our knowledge, this is the first report where sub-colonies of human embryonic stem cells have been
analyzed both at the genomic as well as transcriptome level. The method of this proof of concept study may find
useful practical applications for cases where only a limited number of cells are available, e.g. for tissues samples from
biopsies, tumor spheres, circulating tumor cells and cells from early embryonic development. The results we present
demonstrate that a combined analysis of genomic DNA and messenger RNA from ultra-low input samples is feasible
and can readily be applied to other cellular systems with limited material available.
Keywords: Next generation sequencing, RNA-seq, Whole-genome sequencing, Ultra-low input sequencing, Single cell,
Pluripotency, Embryonic stem cellsBackground
Within recent years an overwhelming number of specific
methods and protocols emerged for next-generation se-
quencing [1]. Amongst them, transcriptome as well as
whole-genome sequencing were of prime interest. Both se-
quencing methods have tremendously accelerated our un-
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functional cell. Transcriptome sequencing focuses on deci-
phering the complex expression pattern of RNAs [2, 3],
therefore identifying novel expressed RNAs and transcript
variants as well as isoforms which in turn lead to a better
understanding of cell regulation, function and networks.
Whole-genome sequencing has for example highlighted in-
sights into the subtle differences amongst the human popu-
lation [4, 5] or major genomic re-arrangements found in
cancer cells [6] with both having a significant impact on cell
fate and the living organism.is distributed under the terms of the Creative Commons Attribution 4.0
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cing libraries for RNA-seq as well as DNA-seq have
emerged [7, 8]; continually reducing the input amount
needed which is generally in the microgram range.
Within recent years the field of single-cell sequencing
for transcriptome and genome sequencing has advanced
significantly [9, 10]. There are already many examples
available were either RNA [11–15], or DNA [8, 16, 17]
have been analyzed down to the single-cell resolution.
Recently, studies with the combined analysis of the gen-
ome and transcriptome of the same cell have also been
published [18, 19]. This is especially advantageous for
applications where only a small fraction of the sample
should be analyzed, or more importantly, where the
sample is composed of a few cells only. Such scenarios in-
clude for example early embryonic development which
starts from a single cell expanding to a few dozen cells
within the first developmental stages [20]. The elucidation
of intra-tumor heterogeneity in biopsies [21, 22] as well as
in in-vitro grown primary tumor spheres [23], or the
characterization of circulating tumor cells [24] rely on the
analyses of limited cell material. In addition, in-vitro cul-
tured stem cells from both mouse and human are limited
in the number of cells if sub-population and sub-colony dif-
ferences in terms of gene expression are under investiga-
tion. For all settings, already subtle changes in genome
integrity can have a major impact on the expression and
regulation of RNAs, and proteins within cells.
Despite the advancements for both areas of sequen-
cing minute amounts of either RNA or DNA, an assay
enabling the combined sequencing of RNA and DNA
from the very same sample still in the ultra-low input
range would add to our understanding of the regulation
and developmental processes affected by both, the func-
tion of genome integrity as well as RNA expression and
gene function.
Here we describe a method which enables the prepar-
ation of whole transcriptome amplified cDNA as well as
the generation of whole-genome amplified DNA from
the same ultra-low input material derived from a sub-
colony of in-vitro cultivated human embryonic stem
cells. Firstly, whole transcriptome amplified cDNA was
prepared from mRNA only by using oligo-dT coupled
magnetic beads, following cDNA synthesis, 3'-tailing and
PCR amplification. Secondly, after magnetic coupling of
the mRNA/oligo-dT beads, whole-genome amplified
DNA was prepared from the retained DNA by Phi29
mediated amplification. Both, the amplified cDNA as
well as DNA were subjected to standard procedures for
multiplex short fragment library preparation enabling
Illumina sequencing. Using this approach, both the tran-
scriptome as well as the genome of the same sample
could be analyzed on both levels of nucleic acids present
in cells, the RNA and DNA.Results
Ultra-low input RNA sequencing
In brief, cells for RNA-seq were collected from human
embryonic stem cells (hESCs) serving as biological sam-
ples. Colonies of hESCs were mechanically dissociated
into 200 μm × 200 μm square fragments consisting of
150–200 cells (Fig. 1b). The undifferentiated and pluri-
potent state of the cells was verified by microscopic as-
sessment of morphology (small, densely-packed cells
with high nuclei:cytoplasm-ratio growing in a homoge-
neous monolayer) and positive immunocytochemical co-
staining for the well-established transcription factors
and hESC-markers OCT3/4 and NANOG [25] (Fig. 1b).
The picked sub-colony fragment was directly transferred
into lysis buffer. After cell lysis, the solution was supple-
mented with oligo-dT coupled magnetic micro-beads and
transferred to columns placed in a magnetic field for fur-
ther processing. To selectively enrich mRNA out of the
total RNA, cDNA synthesis was performed with oligo-dT
coupled magnetic beads. After on column cDNA synthe-
sis, beads with cDNA were retained by centrifugation
followed by 5′-tailing and PCR amplification. The size dis-
tribution of amplified cDNA ranged from 200–3000 base
pairs. PCR products were fragmented by sonication to 150
to 300 base pairs and multiplex fragment library prepar-
ation was performed for paired-end Illumina sequencing.
Figure 1 gives an overview of the developed methodology.
In this study we report data from sequencing of two
hESC samples in the low sub-colony range (150–200
cells, Fig. 1b) which were analyzed by 100 base pair
paired-end sequencing on a single flow cell on an Illu-
mina HiSeq instrument. We obtained 314.2 million raw
reads on a single lane, after barcode mapping for sample
allocation we obtained 65.2 million reads for RNA-seq
sample 1 and 58.8 million reads for RNA-seq sample 2
respectively. Furthermore 190.5 million reads belonged
to whole genome sequencing performed for sample 1.
The RNA-seq reads were mapped with Tophat resulting
in 58.9 and 54.7 million mapped reads (90.2 and 93.5 %)
correspondingly. The number of duplicate reads was found
to be 1.9 % for the WGA-DNA sample and 54.6 and 52.8 %
for the RNA-seq sample 1 and 2 respectively. Duplicate
read counts were based on mapped reads with the same
start and end point. In total 11,755 Refseq genes with a read
coverage of ≥ 5 reads were identified (sample 1: 8523; sam-
ple 2: 10,908; overlap: 7676) in both hESC samples.
Next imperative parameters for RNA-seq were deter-
mined based on the Refseq dataset, specifically the total
length of mRNA showing sequence coverage and cover-
age distribution along the 5'- to 3'-orientation. Since we
performed cDNA synthesis by oligo-dT priming it is
common sense to observe a bias towards the 3′-end of
genes, especially for long transcripts (Fig. 2a). The me-
dian length of Refseq cDNAs observed were around
Fig. 1 Method overview for combined sequencing of mRNA and whole genome DNA. a Schematics for sequencing of ultra-low input DNA and
mRNA from a single cell-colony sample. b OCT3/4, NANOG and DAPI staining of cultured human embryonic stem cells. Rectangular cuts
indicating size of sample applied (150–200 cells each). Scale bar =200 μm
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2000 base pairs (lower and upper quartile) with single
cDNAs longer than 10 kb (Fig. 2b). The average cover-
age distribution along the 5'- to 3'-orientation of Refseq
genes was calculated for transcript size intervals of 0–1 kb,
1–2 kb, 2–3 kb, 3–4 kb, 4–5 kb and 5–15 kb. For
transcripts in the range of 1–2 kb normalized coverage was
almost 80 % over the full transcript length with decreasing
coverage towards the last 15 % of bases at the 5′-end. For
transcripts ranging from 2–5 kb normalized coverage was
at least 50 % (Fig. 2a). Subsequently we evaluated the cor-
relation between both RNA-seq samples. This was done by
comparing FPKM values obtained for expressed Refseq
genes resulting in a Pearson’s correlation factor of 0.85 for
RNA-seq sample 1 and sample 2 (Fig. 2c).
To further evaluate the RNA-seq data we used expres-
sion analysis performed with an Illumina BeadArray with
the same hESC line. The BeadArray experiments were
performed with the appropriate amount of mRNA in
comparison to the low input RNA-seq experiments. Acomparison of expressed Refseq genes for both RNA-seq
samples and the Illumina BeadArray showed a high de-
gree of concordance for both methods. For analysis only
genes were included which gave rise to FPKM >0.5 for
NGS data and p-value <0.05 in BeadArray and were con-
sidered significant. In total 13,630 genes were identified
in both RNA-seq samples whereas the BeadArray identi-
fied 10,834 genes. The total overlap between both se-
quencing experiments and the BeadArray was found to
be 3486 Refseq genes. Moreover the overlap for RNA-
seq sample 1 and BeadArray was found to be 4081 and
for RNA-seq sample 2 to be 5172, respectively (Fig. 3a).
Next, a Consensus Pathway Data Base (CPDB) overrep-
resentation analysis was performed to identify congru-
ence of BeadArray and NGS experiments in terms of
overlapping genes and categories (Fig. 3a). Significant
genes from all experiments were analyzed in CPDB for
categories using pathways from KEGG, Reactome,
BioCarta and Wikipathways and compared for categories
with a p-value threshold of 0.05. In total 506 categories
Fig. 2 Comparison of RNAseq data in terms of transcript identification. a Read coverage across transcripts with coverage for transcripts of sizes
0 kb-1 kb, 1 kb-2 kb, 2 kb-3 kb, 3 kb-4 kb, 4 kb-5 kb and 5 kb-15 kb. Transcripts were divided into 40 equally sized bins and coverage was
averaged over all transcripts of the dedicated size interval. Mean values of mRNA sample1 and sample2 are displayed, error bars denoting
standard deviation of samples. b Boxplot of total length of sequenced Refseq genes for RNAseq sample 1 and sample 2. c Correlation plot for
RNAseq sample 1 and sample 2 in terms of FPKM values for expressed Refseq genes
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415 categories for RNA sequencing sample 1 and sample 2
respectively. Overall overlap for all experiments was found
to be 238 and for BeadArray and combined RNA samples
322 categories. For RNA sequencing sample 1 and RNA
sample 2 only the overlap was found to be 320 categories.
To evaluate pluripotency of hESC samples in BeadArray
and RNA sequencing experiments common pluripotency
marker genes were compared. Comparison was performed
after normalization of gene expression by graphical repre-
sentation analysis (Fig. 3b). The differential analysis of gene
expression showed highest similarity between both RNAsamples followed by BeadArray. Analysis of expressed
genes among all samples showed clustering of genes in
groups of two for DNMT3B and CD9, SOX2 and NANOG
and POU5F1 (OCT3/4) and IFITM1 with very similar gene
expression in BeadArray and both RNA sequencing sam-
ples. Examples of sequencing coverage for single pluripo-
tency marker genes (NANOG, POU5F1 and SOX2) as well
as housekeeping gene (ACTB) are shown in Fig. 4b.
One inherent advantage of RNA-seq over microarray-
based analysis is the identification of splice variants and
isoforms. Hence both RNA-seq samples were analyzed
for expressed isoforms focusing on genes which are
Fig. 3 Overlap between microarray and sequencing measurements. a.1 Venn diagram displaying overlap of significant genes found in the
Illumina microarray and next-generation sequencing (NGS) experiments. Genes expressed with Illumina detection p-value < 0.05 in the microarray
experiment or FPKM > 0.5 in the NGS experiments were considered significant. Genes were compared via HGNC gene symbol annotation.
a.2 Venn diagram displaying overlap of significant CPDB categories found in the Illumina microarray and deep sequencing experiments.
Significant genes from microarray and NGS experiments were analysed with the CPDB functional annotation tool and categories with a q-value
<0.05 were considered significant. b Pluripotency associated genes from microarray experiment and NGS experiments of sample1 and sample2
were compared. Logarithmic values (base 2) of Illumina average signals and FPKM values from expressed genes (detection p-value < 0.05, FPKM >
0.5) were quantile normalized and subjected to cluster analysis via R heatmap2 function using Euclidean distance as distance measure
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differentiated and pluripotent state of both hESCs and
induced pluripotent stem cells (Table 1).
Ultra-low input whole genome sequencing
The sequencing of DNA was performed from the same
sample as the sequencing of mRNA. The DNA contained
in the human embryonic stem cells was collected during
magnetic coupling of the mRNA/oligo-dT complexes and
before cDNA synthesis was performed (Fig. 1a). The
retained DNA was subjected to Phi29 mediated whole
genome amplification (WGA) producing high molecular
mass DNA. The WGA DNA was subjected to sonication
(range 200–250 base pairs), followed by paired-end frag-
ment library preparation and multiplex sequencing on the
same flow cell as the mRNA samples on an Illumina
HiSeq instrument. In total 190.5 million reads corre-
sponding to the DNA of sample 1 were obtained. From
these 153.5 million reads (80.6 %) could be mapped to
hg19, giving rise to an average 6-fold genome coverage.
The coverage for individual chromosomes ranged from 3-fold coverage for the X-chromosome to 13-fold coverage
for chromosome 19 respectively. Furthermore chromo-
some coverage on a single base pair resolution was
found to be ≥90.0 % for twelve chromosomes (chromo-
somes 2–5, 7, 10–12, 17–20). Lowest coverage was
observed for the Y-chromosome with 34.2 % of se-
quenced bases. The average coverage for the full set of
chromosomes was 82.8 % sequenced base pairs. A se-
quencing coverage overview over all chromosomes is
presented in Fig. 4a.
Discussion
To date the vast majorities of analyses of minute amounts
of cell material down to single cells for next generation se-
quencing are still limited to either transcriptome or gen-
ome sequencing [9, 10]. Aiming the great advantages of a
combined analysis, latest studies include different ap-
proaches for genome and transcriptome sequencing of the
same cell [18, 19, 26]. Within the pre-NGS era the analysis
of single cells was performed by a combination of
microarray-based techniques for gene expression and
Fig. 4 Read coverage of genome sequencing and RNA-seq data. a Read coverage of genomic DNA is visualized in a Manhattan plot showing
coverage of 10 kb regions over chromosomes. b Example of mapped reads for selected stem cell marker genes (NANOG, POU5F1, SOX2,) and
housekeeping gene (ACTB) for both RNA-seq samples (light grey: RNA-seq sample1 and medium grey: RNA-seq sample2) and WGA DNA sample
(dark grey). The aligned RNA-seq reads resemble the exon structure depicted below
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errations from the same cell [27]. Enabling a profound
transcriptome as well as genome analysis by next gener-
ation sequencing from minute amounts of sample mater-
ial will have many applications and will enable the study
of rare cells. These rare cells may originate from cell-type
specific differentiation of stem cells, but also from cancer
tissue [22], circulating tumor cells [28] and early embry-
onic development [11] amongst others. Furthermore, it is
known that micro-heterogeneity plays a fundamental role
not only for stem cell function but for many biological
processes [29]. Having tools to dissect these micro-
heterogeneities on a transcriptomic as well as genomiclevel can help to further understand the underlying func-
tion of biological processes and might become of clinical
relevance not only in cancer therapies but also in person-
alized medicine like pharmacogenomics or prenatal
diagnosis.
Our results demonstrate that a combined transcrip-
tome and genome analysis is feasible from minute
amounts of sample material. Sequencing was performed
from 150–200 hESC which equals about 200 pg total
RNA according to the findings of Islam et al. [30] and
about 1 ng of DNA for a diploid genome. In our ap-
proach the developed method for combined transcrip-
tome and genome sequencing generated robust and
Table 1 Detected isoforms of selected human embryonic stem cell marker genes
Gene Nearest ref ID Locus Length Sample1 FPKM Sample2 FPKM Number of isoforms
DNMT3B 212.59 132.05 4/7 (13)
NM_006892 chr20:31350190-31397167 789 9.71 4.87
NM_006892 chr20:31350190-31397167 721 0.00 3.00
NM_006892 chr20:31350190-31397167 3463 18.81 0.00
NM_006892 chr20:31350190-31397167 4131 0.00 21.60
NM_006892 chr20:31350190-31397167 4203 175.74 0.54
NM_006892 chr20:31350190-31397167 4336 8.33 65.00
NM_175848 chr20:31350190-31397167 4276 0.00 29.39
NM_175849 chr20:31350190-31397167 4087 0.00 7.65
NANOG 3.91 6.62 1/1 (1)
NM_024865 chr12:7941994-7948655 2089 3.91 6.62
POU5F1 507.35 484.58 3/2 (21)
NM_001173531 chr6:31132113-31138451 1247 156.01 0.00
NM_002701 chr6:31132113-31138451 1401 348.96 483.12
NM_203289.6 chr6:31132113-31138451 1733 2.38 1.46
Gene expression is shown in FPKM values including detected isoforms. Number of detected isoforms for RNA-seq sample1 and sample2 are separated by dash;
total number of known isoforms in brackets
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etc. on one hand and the genome on the other hand.
This appears an especially advantageous situation in the
case of studying cancer where remarkable chromosome
instability causes genome heterogeneity and is directly
linked to alterations in transcriptome dynamics [31].
The effect of genomic copy number variations and SNPs
on the transcriptome has been investigated with an inte-
grative approach [32]. A further elucidation of the im-
pact of genomic alterations on the phenotype of a cell
can be analyzed preferentially by the presented method,
where DNA and RNA are sequenced from the very same
cell material.
Obtaining full length coverage of expressed genes is
vital for the identification of isoforms and splice variants.
Therefore we specifically evaluated the average coverage
along Refseq genes from the 5'- to the 3'-end. We found
noteworthy variation in terms of average coverage from
the 5'- to the 3'-end with significant more reads
observed at the 3′-end of the transcript. Hence our
RNA-seq data reflect a bias towards the 3'-end mainly
attributed to the application of oligo-dT primed cDNA
preparation. This finding is in agreement with findings
of other groups who analyzed minute amounts of sample
material down to single cells [1, 11, 28, 33]. Other proto-
cols offer highly multiplexed single-cell sequencing,
nevertheless only a limited number of bases either from
the 5'-end [30] or the 3'-end [34] are sequenced to en-
able mainly gene expression studies. The duplication
rate for mapped reads found in both RNA-seq samples
is in line with comparable approaches eg by Adiconis
et al. [35] where also an oligo-dT RNA preparation wasperformed and a duplication rate for low input samples
of ~20 % (SMARTseq) and ~90 % (TRUseq) was re-
ported. In their publication Dey et al. [18] do not
present any information about duplicate reads observed
in DNAseq and RNAseq, presumably due to their
unique combined RNA and DNA amplification ap-
proach. The number of duplicate read counts observed
by Macaulay et al. [19] ranged from 10 to <50 % for gen-
ome sequencing depending on cell line and cell number
analyzed, unfortunately no read count for duplicate
reads are given for RNA-seq, only the number of total
and mapped reads are presented. Therefore the duplicate
reads we found for RNA-seq seem currently more or less
normal, nevertheless it is desirable to reduce the number
in future, to make sequencing more efficient.
Purification of mRNA from the much more abundant
ribosomal RNA using magnetic micro beads coupled to
oligo-dT primers has become a widely established
method in the last years. The recovery of complemen-
tary poly-T sequences is relatively high, whereas non-
target RNAs represent an insignificant part of the
enriched molecules [36]. Beyond the high target selectiv-
ity, the practicability and short assay duration of the
method, further advantages are its compatibility to mod-
ifications. It has been shown that chemical conditions
can also be changed to preserve proteins in their native
state for further proteomic analyses [37]. However, the
abovementioned 3′ skew bias has been faced in different
approaches, like the cDNA transcription using SMAR-
Ter [28] or the additional mRNA enrichment by its 5′
cap [38, 39]. The latter procedure also deals with the in-
tricate capturing of mRNAs with short poly-A tails since
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tional control [40]. Some new protocols avoid a physical
separation of RNA from DNA because it might be detri-
mental when automatic liquid handling is conducted in
small volumes. In such approaches, the oligo-dt primer
contains an additional barcode sequence to identify the
amplified cDNA within the pool of genomic DNA [41].
The limitation of all methods using oligo-dT primer to
target polyadenylated mRNA is the inability to detect
microRNAs or lncRNAs, which are also of importance
for the transcriptome and the cell’s phenotype.
All current NGS platforms require prior amplification
of DNA if minute amounts of DNA are analyzed. Novel
approaches specifically utilized for single-cell whole gen-
ome amplification promise an improved genome cover-
age [17]. However, compared to established methods
locus dropout is still observed and comparable to the re-
sults we obtained for whole genome sequencing. Alter-
natively a transposon-mediated library preparation
strategy omitting any amplification reaction prior to
NGS library preparation [8] may offer an alternative ap-
proach for the method presented here.
Several aspects of the presented method offer room
for improvement. Beyond the separation of the mRNA
the preparation of amplified cDNA as well as WGA
DNA involves many discrete steps which are prone for
technical variation, such as the magnetic coupling and
binding of mRNA to the column, the elution of DNA
from the column, the PCR amplification of the double-
stranded cDNA and library preparation which adds an-
other step of PCR amplification. Secondly, retaining full
length coverage of expressed RNAs in ultra-low input
preparations is especially challenging. Furthermore locus
drop out on the genomic DNA is more likely to occur
with decreasing cell numbers within the WGA reaction.
All these technical challenges are exacerbating if the cell
number is decreased down to single cells and all cur-
rently available methods need to cope with [10].
Conclusion
In conclusion the presented approach for combined
ultra-low mRNA and whole-genome sequencing from
minute amounts of starting material offers new possibil-
ities for many applications where limited material is
available. Furthermore it enables one to directly study
both the transcriptome and genome in one analytical ap-
proach from the same sample material which might be
of interest for both basic as well as clinical research.
Methods
Cell culture and cell picking
Human embryonic stem cells (line H1) were obtained
from WiCell Research Institute. Cells were cultured in
6-well-plates (TPP) coated with Matrigel (BectonDickinson) on Mitomycin C-inactivated mouse embry-
onic fibroblasts (MEFs) as described before [42]. After
1 week, undifferentiated colonies were mechanically
fragmented using the StemProEZPassage Disposable
Stem Cell Passaging Tool (Invitrogen, cat# 23181–010)
according to the recommendations of the manufacturer,
leading to squares of relatively uniform size (ca. 200 μm ×
200 μm, see Fig. 1b). Fragments from the middle of undif-
ferentiated colonies were detached using a non-rotatable
cell spatula (TPP, cat#99010) under microscopic control
(Stereo microscope Leica MZ9.5 with cold light source KL
1500 LCD; Leica Microsystems) and sterile conditions in-
side a HERAguard® HPH 9 Laminar flow clean bench
(Heraeus). Detached single squares were individually iso-
lated by very gentle aspiration using a sterile 20 μl filter
pipette tip (Biozym Scientific) and used for further down-
stream processing.
Immunocytochemistry
Cells were fixed with 4 % paraformaldehyde (Electron
Microscopy Sciences) in PBS (Gibco/Invitrogen) for
15 min, washed two times with PBS and then stained as
described before [42]. Primary antibodies: anti-OCT3/4
(C-10) Mouse monoclonal antibody (Santa Cruz
Biotechnology, cat#sc-5279) and anti-NANOG Goat
polyclonal antibody (R&D Systems, cat#AF1997). Sec-
ondary antibodies: anti-Mouse IgG (H + L) (from
chicken) labelled with red-fluorescent Alexa Fluor594
(Invitrogen, cat#A-21201) and anti-Goat IgG (H + L)
(from donkey) labelled with green-fluorescent Alexa
Fluor488 (Invitrogen, cat#A-11055). Nuclei were coun-
terstained with DAPI. Fluorescence microscopy and
photographing was performed using Axiovert 200 M
(Zeiss) and Software AxioVision Rel. 4.8 (Zeiss).
Ultra low input cDNA and WGA-DNA preparation
Preparation and amplification of nucleic acids were per-
formed with a customized version of the μMACS Super-
Amp Kit (Miltenyi Biotec); if not mentioned explicitly,
procedures were according to the manufacturer proto-
col. The protocol is based on magnetic coupling of
mRNA and retaining the nucleic acid in low volume
flow-through columns for greatly simplified handling.
For selective mRNA isolation, magnetic micro beads
coupled to oligo-dT primers were applied. To retain the
genomic DNA the eluates from the first two washing
steps after loading the cell lysate onto the column were
collected into a 1.5 mL reaction tube for later DNA pre-
cipitation and whole genome amplification. On column
cDNA synthesis was performed at 42 °C for 60 min ac-
cording to the following protocol by applying the total
reaction master mix onto the column: 20 μL contained
2 μL 10× Reverse Transcriptase Buffer (Ambion),
0.5 mM dNTPs, 1 μg T4 Gene 32 Protein (NEB), 400 U
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RNase Inhibitor (Ambion). After collection of magnetic
beads containing synthesized cDNA by centrifugation
and 3'-tailing according to the manufacturer, PCR ampli-
fication was performed. To the 3'-tailing reaction, in
total 30 μL, the following PCR master mix was added:
76.5 μL PCR master mix contained 14 μL 5× Phusion
HF buffer (Finnzymes), 0.5 mM dNTPs, 60 μL resus-
pended μMACS SuperAmp PCR mix, 2 U PhusionTaq
(Finnzymes); the following cycling conditions were ap-
plied on a PTC-200 (MJ Research) thermal cycler: 78 °C
for 30 s, 95 °C for 1 min, [98 °C for 3 s, 64 °C for 30 s,
72 °C for 2 min]× 40 cycles, 72 °C for 5 min.
Amplification of genomic DNA was performed with
the REPLI-g Midi Kit (Qiagen) for 16 h at 30 ° C accord-
ing to the manufacturer’s recommendations. Before
whole genome amplification, DNA was ethanol precipi-
tated by adding 0.1 volumes of 3 M sodium acetate solu-
tion and 5 μg glycogen (Ambion) to 1 volume of DNA
sample. After precipitation the pellet was resuspended in
10 μL of Elution Buffer (Qiagen).
Library preparation and NGS
Library preparation for next generation sequencing was
performed according to the Illumina TruSeq DNA
Sample Preparation Guide with the Low-Throughput
protocol. The indexed paired‐end libraries had an insert
size in the range of 150–300 base pairs. Subsequent
pooling of the samples with a ratio of 3:1:1 (wgaD-
NA:mRNA1:mRNA2) cluster generation and DNA se-
quencing was performed on a single lane of an
IlluminaHiSeq instrument with a 100 base pair paired-
end sequencing chemistry.
Mapping and data analysis
RNA-seq mapping
RNA-seq data was mapped to the human genome by
Tophat v1.3.3. Prebuild bowtie index files and annotations
in GTF-format were downloaded from Illumina’s
iGenomes ftp-server (ussd-ftp.illumina.com/Homo_sa-
piens/UCSC/hg19/). Duplicate read counts were estimated
on mapped reads using Picard (http://broadinstitute.githu-
b.io/picard/). To compare Tophat mappings to Illumina
BeadArray data, we considered only reads that mapped to
annotated exons (UCSC genes) and reached peak coverage
of 5 or higher. Furthermore we restricted the analysis to
Refseq genes.
Whole genome mapping
Genomic DNA sequencing reads were mapped using bow-
tie with the same parameters that Tophat uses for its first
mapping round (−v 2). Duplicate read counts were esti-
mated on mapped reads using Picard (http://broadinstitu-
te.github.io/picard/). Genomic coverage was visualized asManhattan plot via the mhtplot function from the R pack-
age gap.
Transcriptome read coverage analysis
Coverage was calculated via the IGVtools command count
[43] from the exon aligned BAM files for RNA sample1
and sample2 using default settings. For transcript coverage
window size 25 was used, for genomic coverage window
size 10,000 was used. Transcript calculations were based
on exon unions of human genes from ENSEMBL V74 for
plus and minus strand separately. Each transcript was di-
vided into 40 equally sized bins according to the method
of [28]. To compensate for missing values data points cor-
responding to the 40 bins were determined by
interpolation of the IGVtools results via cubic spline curve
fitting (function spline) from the statistical software pack-
age R. Resulting values were normalized via division by
the maximum. These transcript coverages were averaged
for transcript size intervals 0 kb −1 kb, 1 kb −2 kb,
2 kb −3 kb, 3 kb −4 kb, 4 kb −5 kb and 5 kb −15 kb. Plus
and minus strand were summarized by calculating mean
values for all transcript size intervals. Finally, mean values
and standard deviations were determined between the two
RNA samples shown in the coverage plots. Boxplots of se-
quenced mRNA length were plotted by the R package.
Overlap between microarray and sequencing
measurements
Congruence of Illumina microarray and next generation
sequencing experiments was determined in terms of over-
lapping genes and overlapping categories found via
Consensus Pathway Data Base (CPDB) overrepresentation
analysis [44]. Genes were considered significantly
expressed when the FPKM (Fragments per kilobase of
exon per million fragments mapped) values were greater
than 0.5 in the sequencing experiments or Illumina detec-
tion p-value was less than 0.05. Additionally, these genes
were subjected to a CPDB overrepresentation analysis
using pathways from KEGG, Reactome, BioCarta and
Wikipathways and the resulting categories were compared
using a threshold of 0.05 for p-values adjusted via the
Benjamini-Hochberg method. The results were displayed
in Venn diagrams from R package Vennerable.
Cluster analysis of pluripotency associated genes
Illumina average signals from microarray experiment and
FPKM values from sequencing experiments of sample1
and sample2 were compared with respect to pluripotency
associated genes [29] which were expressed in the micro-
array experiment (detection p-value < 0.05) and in the se-
quencing experiments (FPKM> 0.5). Logarithmic values
(base 2) of these measurements were quantile normalized
and subjected to cluster analysis via R heatmap2 function
using Euclidean distance as distance measure.
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